Delivery Order SPE2DB22D1041-SPE2DB24FUCT8

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $8.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 ml pen injectors. The fixed-price delivery order, valued at $12,343.56, has an ultimate completion date of September 20, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through December 2025, to deliver a wide range of medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,873.98 firm fixed-price delivery order contract is for the supply of Imitrex 6 mg/0.5 ml pen injections. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,710.70, is for the supply of Imitrex 6 mg/0.5 ml pen injections to support military healthcare programs. The contract has an ultimate completion date of May 30, 2024. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC)...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order with a ceiling value of $2,237.58 under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Imitrex 6 mg/0.5 ml pen injectors to federal medical facilities. No set-aside designation is specified. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,439.13 firm fixed-price delivery order is for the supply of Imitrex 6 mg/0.5 ml pen injectors, with an ultimate completion date of August 2, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
The federal contract award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the provision of Imitrex 6 mg/0.5 ml pen injectors. This is a firm fixed price delivery order with a ceiling value of $1,355.16 and a period of performance through April 12, 2024. The contract does not have a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,510.23, is a Firm Fixed Price Delivery Order for the provision of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a medication used to treat migraines. The contract has an ultimate completion date of May 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order valued at $8,495.68 for the supply of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price pricing type and an ultimate completion date of November 27, 2024. The award was made on November 26, 2024, and there was no set-aside designation used. Amerisourcebergen...
This is a Delivery Order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Imitrex 6 mg/0.5 mL Injection Pens. The contract has a ceiling value of $3,681.36 and a completion date of May 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,378.79, is for the delivery of IMITREX 6 MG/0.5 ML PEN INJECT 0.5ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through January 31, 2025. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUCT8
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $8,494.69, is a delivery order for Imitrex 6 mg/0.5 ml pen injectors. The contract is a firm fixed-price agreement with an ultimate completion date of July 24, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/17/25, 9:48 AM